user

Topas Therapeutics to Participate at Upcoming Industry and Scientific Conferences

HAMBURG / ACCESSWIRE / March 20, 2019 / Topas Therapeutics GmbH (Topas), a Hamburg, Germany-based private platform company leveraging the…

6 years ago

Budget 2019: Collaboration is Essential to Success of National Pharmacare

OTTAWA, ON / ACCESSWIRE / March 19, 2019 / Innovative Medicines Canada (IMC) welcomes the measures taken in Budget 2019…

6 years ago

Intellipharmaceutics Receives Nasdaq Listing Determination; To Begin Trading on the OTC Markets System

TORONTO, ON / ACCESSWIRE / March 19, 2019 / Intellipharmaceutics International Inc. (Nasdaq and TSX: IPCI) ("Intellipharmaceutics" or the "Company"),…

6 years ago

ReShape Lifesciences to Host Fourth Quarter and Full Year 2018 Conference Call on April 1, 2019

SAN CLEMENTE, CA / ACCESSWIRE / March 19, 2019 / ReShape Lifesciences Inc. (OTCQB: RSLS), a developer of minimally invasive…

6 years ago

Aytu BioScience Announces Two Recent Publications Highlighting Improved Efficacy and Patient Preference of Natesto Nasal Testosterone over Topical Gels

Natesto ''MY-T study'' - First Study to Demonstrate Improvement of Low T Symptoms in Men After Switching to Natesto from…

6 years ago

Schlomo Schmuel & Sunset Foot Clinic set to Relocate in Coming Months

The Sunset Foot Clinic - home of the famous Happy Foot Sad Foot spinning logo on Sunset Boulevard in Silver…

6 years ago

Nevada Facility Runs Test of New Processing System

VANCOUVER, BC / ACCESSWIRE / March 19, 2019 / EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the "Company") is…

6 years ago

Evotec And GARDP Announce New Partnership To Discover Novel Antibiotics

COLLABORATION EXPLORES OPPORTUNITIES TO SET UP ANTIBIOTIC DISCOVERY AND DEVELOPMENT PLATFORM AND ESTABLISH A JOINT PIPELINE OF NOVEL ANTIBIOTIC ASSETS…

6 years ago

Cerecor Reports Fourth Quarter and Full Year 2018 Results

-Significant Advancement in Pipeline and Regulatory Milestones-Meets Increased 2018 Revenue Guidance-Announces Net Revenue Guidance of $20-22 Million for 2019 ROCKVILLE,…

6 years ago

Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2019

DORADO, PUERTO RICO / ACCESSWIRE / March 18, 2019 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB: PBSV),…

6 years ago

Champions Oncology Reports Quarterly Revenue of $6.4 Million

Reiterates Expectations for Revenue Growth of at Least 20% for Fiscal Year 2019 HACKENSACK, NJ / ACCESSWIRE / March 18,…

6 years ago

Holistic Medicine Practice In Brooklyn NY Announces New Website Launch

BROOKLYN, NY / ACCESSWIRE / March 18, 2019 / Dr. Kamau Kokayi with Healing Health Services in Brooklyn, New York,…

6 years ago

Sterna Biologicals Holds Scientific Advisory Board Meeting at 14th Congress of ECCO to Advance Phase IIb Clinical Development Program of SB012 in Ulcerative Colitis

- Meeting included international key opinion leaders - Input provided on SB012 development plan and phase IIb trial protocol MARBURG,…

6 years ago

Easton Announces Filing of Its Financial Statements for the Year Ended December 31, 2018 with a Revenue Increase of 145% Over 2017 and Provides General Business Update

TORONTO, ON / ACCESSWIRE / March 18, 2019 / Easton Pharmaceuticals, Inc. (OTC PINK: EAPH) Announces that it has filed…

6 years ago

Ozop Surgical Corp Provides Corporate Update and Outlook for 2019

WEST PALM BEACH, FL / ACCESSWIRE / March 18, 2019 / Ozop Surgical Corp. (OTCQB: OZSC), a provider of premium…

6 years ago

WNDM Medical Inc. Acquires Remaining 50% Interest in Cellerate, LLC from an Affiliate of The Catalyst Group, Inc; Elects Ron Nixon to its Board of Directors

FORT WORTH, TX / ACCESSWIRE / March 18, 2019 / WNDM Medical Inc. (OTCQB: WNDM) Based in Fort Worth, Texas,…

6 years ago

Hancock Jaffe Announces Successful Start to CoreoGraft Study at Texas Heart Institute

Excellent Initial Flow Rates Achieved with CoreoGrafts for Bypasses Completed in Two Test Subjects IRVINE, CA / ACCESSWIRE / March…

6 years ago

Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.) Announces Entry into the CBD Market

SACRAMENTO, CA / ACCESSWIRE / March 18, 2019 / Falcon Technologies, Inc. (OTC PINK: FLCN) announced today its immediate entry…

6 years ago

AXT107 Restores Healthy, Non-Leaky Vasculature in the Eye by Inhibiting VEGFR2 and Activating Tie2, the Two Clinically Validated Pathways in Diseases of the Retina

AXT107 exhibited a dual mechanism of action as a monotherapy, disrupting a key component of the Vascular Endothelial Growth Factor…

6 years ago

RMS Medical Products to Present at the 29th Annual Oppenheimer Healthcare Conference

CHESTER, NY / ACCESSWIRE / March 15, 2019 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today…

6 years ago